Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...
Sep 18, 2023
1
46
Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
47
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, have published a new study explaining how they took a protein once thought to be too challenging for targeted ...
Aug 1, 2023
0
200
With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.
Jul 17, 2023
0
40
An experimental "decoy" has provided long-term protection from infection by the pandemic virus in mice, a new study finds.
May 30, 2023
0
48
Is it possible to improve the antibodies that the body produces to fight SARS-CoV2? In a study led by researchers from Lund University in Sweden, this was investigated by redesigning antibodies and combining them against ...
Apr 18, 2023
0
108
The human body is capable of creating a vast, diverse repertoire of antibodies—the Y-shaped sniffer dogs of the immune system that can find and flag foreign invaders. Despite our ability to create a range of antibodies ...
Apr 6, 2023
0
130
Biologics, a class of therapeutics derived from living organisms, offer enormous advantages to patients battling challenging diseases and disorders. Treatments based on biologics can boost the immune system to stem attacks ...
Mar 31, 2023
0
65
New research from Oregon Health & Science University and collaborators indicates that lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.
Mar 29, 2023
0
52
A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators ...
Mar 8, 2023
0
111
